Loss of desmoglein 2 promotes tumor growth and progression through the activation of Src and facilitates the internalization of EGFR in biliary tract carcinoma cells

被引：1

作者：

Lee, Sang-Hyun ^{[1
]}

Min, Jeong-Ki ^{[1
]}

机构：

[1] Korea Res Inst Biosci & Biotechnol, Daejeon, South Korea

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-1082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1082

引用

页数：2

共 50 条

[1] Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation
Lee, Sang-Hyun
Kim, Jin-Man
Lee, Dong Gwang
Lee, Jangwook
Park, Jong-Gil
Han, Tae-Su
Cho, Hyun-Soo
Cho, Young-Lai
Bae, Kwang-Hee
Park, Young-Jun
Lee, Seon-Jin
Lee, Moo-Seung
Huh, Yong-Min
Jo, Deog Yeon
Yun, Hwan-Jung
Jeon, Heung Jin
Kim, Nayoung
Joo, Mina
Kim, Jang-Seong
Lee, Hyo Jin
Min, Jeong-Ki
CELL DEATH AND DIFFERENTIATION, 2021, 28 (03): : 968 - 984
[2] Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation
Sang-Hyun Lee
Jin-Man Kim
Dong Gwang Lee
Jangwook Lee
Jong-Gil Park
Tae-Su Han
Hyun-Soo Cho
Young-Lai Cho
Kwang-Hee Bae
Young-Jun Park
Seon-Jin Lee
Moo-Seung Lee
Yong-Min Huh
Deog Yeon Jo
Hwan-Jung Yun
Heung Jin Jeon
Nayoung Kim
Mina Joo
Jang-Seong Kim
Hyo Jin Lee
Jeong-Ki Min
Cell Death & Differentiation, 2021, 28 : 968 - 984
[3] Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma
Jin, Runsen
Wang, Xinfeng
Zang, Ruochuan
Liu, Chengming
Zheng, Sufei
Li, Hecheng
Sun, Nan
He, Jie
CANCER LETTERS, 2020, 483 : 46 - 58
[4] Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway
Bajpai, Deepti
Mehdizadeh, Spencer
Uchiyama, Akihiko
Inoue, Yuta
Sawaya, Andrew
Overmiller, Andrew
Brooks, Stephen R.
Hasneen, Kowser
Kellett, Meghan
Palazzo, Elisabetta
Motegi, Sei-ichiro
Yuspa, Stuart H.
Cataisson, Christophe
Morasso, Maria, I
ONCOGENE, 2021, 40 (21) : 3680 - 3694
[5] Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR–ERBB2 pathway
Deepti Bajpai
Spencer Mehdizadeh
Akihiko Uchiyama
Yuta Inoue
Andrew Sawaya
Andrew Overmiller
Stephen R. Brooks
Kowser Hasneen
Meghan Kellett
Elisabetta Palazzo
Sei-ichiro Motegi
Stuart H. Yuspa
Christophe Cataisson
Maria I. Morasso
Oncogene, 2021, 40 : 3680 - 3694
[6] Epidermal growth factor receptor inhibition promotes desmosome adhesion by blocking MMP-dependent processing and internalization of desmoglein 2 in squamous cell carcinoma cells
Klessner, J
Stack, M
Green, KJ
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A34 - A34
[7] Loss of G-Protein Pathway Suppressor 2 Promotes Tumor Growth Through Activation of AKT Signaling
Chan, Stefanie
Smith, Emma
Gao, Yuan
Kwan, Julian
Blum, Benjamin C.
Tilston-Lunel, Andrew M.
Turcinovic, Isabella
Varelas, Xaralabos
Cardamone, Maria Dafne
Monti, Stefano
Emili, Andrew
Perissi, Valentina
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
[8] Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects
Jia, Xiao-hua
Feng, Guo-wei
Wang, Zhong-liang
Du, Yang
Shen, Chen
Hui, Hui
Peng, Dong
Li, Zong-jin
Kong, De-ling
Tian, Jie
ONCOTARGET, 2016, 7 (15) : 20934 - 20944
[9] EGFR activation enhances cyclooxygenase-2 expression and tumor growth through activation of β2-adrenergic receptor in esophageal squamous cell carcinoma
Liu, X.
He, Z.
Zhang, S-T
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 2 - 2
[10] EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3
Mengxian Tu
Lu He
Yang You
Jinying Li
Nan Yao
Chen Qu
Wei Huang
Leibo Xu
Rongcheng Luo
Jian Hong
Cell Death & Disease, 11

← 1 2 3 4 5 →